This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
The AHFS DI is one of several compendiums approved by the Social Security Act (Section 1861(t)(2)(B)(ii)(I)) as a source of off-label anti-cancer drug use. It was originally published in 1959 as the American Hospital Formulary Service (AHFS) by the American Society of Health-System Pharmacists,
It is also the only one left of the originally authorized compendiums.
- "Gain a solid understanding of compendia and its impact on patient access". Formulary Journal. 2012-07-01. Retrieved 2018-03-30.
- ElizabethHalpern, Hogan Lovells-; Langbein, Stuart M.; Manning, Meredith; Roberts, Beth L.; Lakhani, Ali. "And then there were five: CMS approves Wolters Kluwer Lexi-Drugs® as the fifth recognized authoritative compendium | Lexology". Retrieved 2018-03-30.
- "Medical Coverage Document". Centers for Medicare & Medicaid Services. cms.gov. Retrieved 6 January 2018.
- Abernethy, Amy (October 2012). "Role of Compendia in Determining what Drugs are Reimbursed". National Science Foundation.
- Butcher, Lola (2008-06-25). "Compendia Decisions Impact Off-Label Coverage". Oncology Times. 30 (12): 29–30. doi:10.1097/01.COT.0000326167.89228.b6. ISSN 0276-2234.